Equities
  • Price (EUR)1.56
  • Today's Change0.055 / 3.67%
  • Shares traded-1.00
  • 1 Year change-46.84%
  • Beta0.9044
Data delayed at least 15 minutes, as of May 21 2024 08:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.

  • Revenue in EUR (TTM)448.00k
  • Net income in EUR-16.29m
  • Incorporated2000
  • Employees18.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oxurion NV263.00k-18.97m1.01m20.00------3.84-0.023-0.0230.0002-0.00380.028463.600.125313,150.00-204.59-84.30---118.7039.5448.90-7,212.55-2,008.990.1398-1.75-----55.80-45.2040.13---65.17--
Diagonal Bio AB1.98k-1.01m1.07m4.00--0.0959--538.25-0.1982-0.19820.00040.32210.0007--2.005,750.00-37.35---44.49---41,604.35---50,769.57--0.5105-104.20-----88.67--27.75------
Rapid Nutrition PLC1.82m-1.45m1.20m9.0039.18541.70--0.66270.00170.00170.00340.00011.843.903.05201,766.30-146.98---1,011.07--71.47---79.74--1.07--0.7674---1.50---1,090.33------
XP Chemistries AB57.19k-692.65k1.40m2.00--0.6328--24.49-0.2846-0.28460.02130.2750.0230.20845.99331,845.00-27.79---29.36--50.57---1,211.24--5.79--0.00---37.14---1.55------
Epigenomics AG448.00k-16.29m1.42m18.00--0.6705--3.16-19.49-19.490.5362.240.03612.733.3413,176.47-131.18-65.64-167.31-83.8576.5689.26-3,636.16-548.191.93--0.1572---92.18-23.61-395.22--44.06--
Aptahem AB2.76k-957.50k1.42m----0.128--513.40-0.0497-0.04970.00010.22660.0005--0.0738---16.76-39.26-19.47-44.194,623.59---34,727.72-----10.170.0847-------25.36------
Private Rented Sector SA47.02k6.40k1.46m--228.27--66.2331.050.02060.02060.1514-0.0351.79--2.20--24.281,266.23----23.89-1,935.5513.602,755.44-------------66.26------
Circio Holding ASA10.59k-9.53m1.61m11.00------151.70-16.75-16.750.0181-12.890.0019--0.007211,181.82-172.29-46.58---53.40-----90,029.27-6,902.00---9.827.73---98.7735.4374.42------
Asarina Pharma AB (publ)0.00-1.11m1.66m----12.34-----0.5704-0.57040.000.0690.00-------113.04-61.28-150.47-71.81------------0.3902------2.79------
Oxford Cannabinoid Tchnlgs Hldngs PLC0.00-4.96m1.72m7.00--0.6649-----0.0044-0.00440.000.0020.00----0.00-82.98-56.41-104.70-66.13------------0.00-------26.16------
Peptonic Medical AB3.36m-3.90m1.72m37.00--0.3101--0.5121-0.0325-0.03250.02880.04190.41851.425.491,055,432.00-48.49-46.02-61.53-60.8544.3454.26-115.88-139.380.5002-140.410.2084---14.93149.65-15.55--27.15--
AegirBio AB8.53k-31.62m1.73m1.00--2.25--203.35-24.31-24.310.00470.28950.00042.000.0207---163.02---171.79---24,398.99---370,710.10--2.53-27.270.8209---87.16---292.98------
Nuformix PLC0.00-511.36k1.77m2.00--0.3282-----0.0006-0.00060.000.00560.00-------9.50---9.95--------------0.00--------------
Lidds AB0.00-3.46m1.82m2.00--0.7585-----0.8316-0.83160.000.20370.00----0.00-184.54-46.33-274.93-51.61---1,934.24---3,076.68----0.00---100.00---9.08------
Theravet SA-100.00bn-100.00bn1.84m--------------------------------------------------------------
Data as of May 21 2024. Currency figures normalised to Epigenomics AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.